DR. DHAVALKUMAR D PATEL, MD
Osteopathic Medicine at Manning Dr, Chapel Hill, NC
License number
North Carolina 9400324
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
101 Manning Dr, Chapel Hill, NC 27599
Phone
(919) 966-4996
(919) 843-5515 (Fax)
(919) 843-5515 (Fax)
Professional information
Dr. Dhavalkumar D Patel, Chapel Hill NC - MD (Doctor of Medicine)
Specialties:
Rheumatology
Address:
101 Manning Dr, Chapel Hill 27514
(919) 966-4996 (Phone), (919) 843-5515 (Fax)
(919) 966-4996 (Phone), (919) 843-5515 (Fax)
Certifications:
Allergy & Immunology, 1999, Internal Medicine, 1992, Rheumatology, 1996
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
101 Manning Dr, Chapel Hill 27514
Duke Health Raleigh Hospital
3400 Wake Forest Rd, Raleigh 27609
Duke University Hospital
2301 Erwin Rd, Durham 27710
Durham Regional Hospital
3643 North Roxboro Rd, Durham 27704
University of North Carolina Hospital
101 Manning Dr, Chapel Hill 27514
Duke Health Raleigh Hospital
3400 Wake Forest Rd, Raleigh 27609
Duke University Hospital
2301 Erwin Rd, Durham 27710
Durham Regional Hospital
3643 North Roxboro Rd, Durham 27704
University of North Carolina Hospital
101 Manning Dr, Chapel Hill 27514
Education:
Medical School
Duke University
Graduated: 1989
Duke University Hospital
Duke U Med Ctr
Duke University
Graduated: 1989
Duke University Hospital
Duke U Med Ctr
Dhavalkumar D Patel, Chapel Hill NC
Specialties:
Rheumatologist
Address:
101 Manning Dr, Chapel Hill, NC 27514
Education:
Duke University, School of Medicine - Doctor of Medicine
Duke University - Doctor of Philosophy
Duke University Hospital - Fellowship - Allergy and Immunology
Duke University Hospital - Fellowship - Rheumatology (Internal Medicine)
Duke University Hospital - Residency - Internal Medicine
Duke University - Doctor of Philosophy
Duke University Hospital - Fellowship - Allergy and Immunology
Duke University Hospital - Fellowship - Rheumatology (Internal Medicine)
Duke University Hospital - Residency - Internal Medicine
Chemokine Parc Suppresses Specific Cytokine Production
US Patent:
2004010, May 27, 2004
Filed:
Sep 12, 2003
Appl. No.:
10/660734
Inventors:
Qin Fu - Baltimore MD, US
Velizar Tchernev - Branford CT, US
Ebenezer Satyaraj - Hamden CT, US
Dhavalkumar Patel - Chapel Hill NC, US
Stephen Kingsmore - Guilford CT, US
Velizar Tchernev - Branford CT, US
Ebenezer Satyaraj - Hamden CT, US
Dhavalkumar Patel - Chapel Hill NC, US
Stephen Kingsmore - Guilford CT, US
Assignee:
Molecular Staging Inc. - New Haven CT
International Classification:
A61K038/19
US Classification:
424/085100
Abstract:
We measured the levels of 78 different cytokines and growth factors in culture supernatants to determine the cytokine profiles of cells treated with PARC. We found that specific cytokines were suppressed by PARC. PARC can be used to treat diseases such as cancer, autoimmune diseases, rheumatoid arthritis, myeloproliferative disorders, and coronary artery disease, which are characterized by too much mitosis.
Methods For Evaluating Osteoarthritis Risk
US Patent:
7662573, Feb 16, 2010
Filed:
Aug 12, 2005
Appl. No.:
11/573711
Inventors:
Shari M. Ling - Ellicott City MD, US
Lorah Perlee - Wilton CT, US
Velizar T. Tchernev - Sofia, BG
Dhavalkumar D. Patel - Chapel Hill NC, US
Luigi Ferrucci - Baltimore MD, US
Ming Zhan - Germantown MD, US
Lorah Perlee - Wilton CT, US
Velizar T. Tchernev - Sofia, BG
Dhavalkumar D. Patel - Chapel Hill NC, US
Luigi Ferrucci - Baltimore MD, US
Ming Zhan - Germantown MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
G01N 33/53, C07K 14/435, C12P 19/34, C12Q 1/68
US Classification:
435 71, 435 72, 435 911, 435 912, 435183, 435 6, 530350, 530351
Abstract:
Methods are provided for evaluating osteoarthritis (OA), for example for diagnosing OA, to confirm a diagnosis of OA, to assess or prognose progression of OA, determining the severity of a subject who has OA, and determining a subject's risk of developing OA in the future, as are arrays and kits that can be used to practice the methods. In particular examples, the method includes determining an amount of activity (such as an amount of protein present or an amount of expression) of OA risk-related molecules, such as soluble vascular adhesion protein 1 (sVAP-1) or interleukin-15 (IL-15). Also provided are methods of identifying one or more compounds that alter the activity of an OA-related molecule, thereby identifying potential anti-osteoarthritis drugs.
Methods For Evaluating Osteoarthritis Risk
US Patent:
2010015, Jun 17, 2010
Filed:
Dec 24, 2009
Appl. No.:
12/647166
Inventors:
Shari M. Ling - Ellicott City MD, US
Lorah Perlee - Wilton CT, US
Velizar T. Tchernev - Sofia, BG
Dhavalkumar D. Patel - Chapel Hill NC, US
Luigi Ferrucci - Baltimore MD, US
Ming Zhan - Germantown MD, US
Lorah Perlee - Wilton CT, US
Velizar T. Tchernev - Sofia, BG
Dhavalkumar D. Patel - Chapel Hill NC, US
Luigi Ferrucci - Baltimore MD, US
Ming Zhan - Germantown MD, US
International Classification:
A61K 49/00, C12Q 1/68, C40B 30/04, C40B 40/10, G01N 33/68, A61K 31/7008, A61K 31/60, A61K 31/192, A61K 31/4025, A61K 31/167, A61K 31/737, A61K 31/65
US Classification:
424 91, 435 6, 506 9, 506 18, 435 71, 514 62, 514165, 514570, 514569, 514411, 514629, 514 54, 514152
Abstract:
Methods are provided for evaluating osteoarthritis (OA), for example for diagnosing OA, to confirm a diagnosis of OA, to assess or prognose progression of OA, determining the severity of a subject who has OA, and determining a subject's risk of developing OA in the future, as are arrays and kits that can be used to practice the methods. In particular examples, the method includes determining an amount of activity (such as an amount of protein present or an amount of expression) of OA risk-related molecules, such as soluble vascular adhesion protein 1 (sVAP-1) or interleukin-15 (IL-15). Also provided are methods of identifying one or more compounds that alter the activity of an OA-related molecule, thereby identifying potential anti-osteoarthritis drugs.
Immunogen
US Patent:
2008021, Sep 4, 2008
Filed:
Sep 14, 2004
Appl. No.:
10/572312
Inventors:
Barton F. Haynes - Durham NC, US
Dhavalkumar D. Patel - Chapel Hill NC, US
Munir Alam - Chaple Hill NC, US
Dhavalkumar D. Patel - Chapel Hill NC, US
Munir Alam - Chaple Hill NC, US
Assignee:
DUKE UNIVERSITY - Durham NC
International Classification:
A61K 39/385, C07K 14/00, C07K 16/00
US Classification:
4241931, 530395, 5303917
Abstract:
The present invention relates, in general, to an immunogen for inducing antibodies that neutralize a wide spectrum of HIV primary isolates. The invention also relates to a method of inducing anti-HIV antibodies using same.
Immunogen
US Patent:
2006020, Sep 14, 2006
Filed:
Feb 14, 2006
Appl. No.:
11/353025
Inventors:
Barton Haynes - Durham NC, US
Dhavalkumar Patel - Chapel Hill NC, US
Munir Alam - Chapel Hill NC, US
Dhavalkumar Patel - Chapel Hill NC, US
Munir Alam - Chapel Hill NC, US
Assignee:
DUKE UNIVERSITY - Durham NC
International Classification:
C12Q 1/70, C12Q 1/68
US Classification:
435006000, 435005000
Abstract:
The present invention relates, in general, to an immunogen and, in particular, to an immunogen for inducing antibodies that neutralize a wide spectrum of HIV primary isolates. The invention also relates to a method of inducing anti-HIV antibodies using same.